Astera Labs CEO Sells $10M in Stock Through Planned Trading Program
Jitendra Mohan, Chief Executive Officer and Director of Astera Labs (ALAB), reported multiple sales of common stock on June 17, 2025, executed through a pre-established Rule 10b5-1 trading plan from December 2, 2024.
Rhea-AI Filing Summary
Jitendra Mohan, Chief Executive Officer and Director of Astera Labs (ALAB), reported multiple sales of common stock on June 17, 2025, executed through a pre-established Rule 10b5-1 trading plan from December 2, 2024.
The transactions involved the sale of 106,510 total shares at a weighted average price of $94.5417 per share across six different trusts. The sales were executed in multiple tranches with prices ranging from $93.36 to $96.78 per share.
Following the transactions, Mohan's holdings are distributed as follows:
- Direct ownership: 2,262,318 shares
- Indirect ownership through various trusts: - Living Trust: 4,351,010 shares - Trust: 771,003 shares - 2021 Trusts: 1,542,014 shares combined - 2022 Trusts: 1,042,016 shares combined
The filing indicates Mohan disclaims beneficial ownership of the trust-held securities except for his pecuniary interest.
Positive
- None.
Negative
- CEO Jitendra Mohan sold 106,510 shares for approximately $10.1M through a pre-planned 10b5-1 trading plan, with sales executed at prices ranging from $93.36 to $96.78 per share
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 17,752 | $94.5417 | $1.68M |
| Sale | Common Stock | 17,752 | $94.5417 | $1.68M |
| Sale | Common Stock | 17,752 | $94.5417 | $1.68M |
| Sale | Common Stock | 17,752 | $94.5417 | $1.68M |
| Sale | Common Stock | 17,751 | $94.5417 | $1.68M |
| Sale | Common Stock | 17,751 | $94.5417 | $1.68M |
| holding | Common Stock | -- | -- | -- |
Footnotes (8)
- F1. The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024.
- F2. The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 15,279 shares sold at prices ranging from $96.7800 to $95.7950, 21,998 shares sold at prices ranging from $95.7750 to $94.7800, 44,589 shares sold at prices ranging from $94.7700 to $93.7800, and 24,644 shares sold at prices ranging from $93.7700 to $93.3600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F3. These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- F4. These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- F5. These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- F6. These shares are owned directly by an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- F7. These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- F8. These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What was the selling price of ALAB stock in Jitendra Mohan's June 2025 transaction?
Was ALAB CEO Mohan's stock sale planned or spontaneous?
AI-generated analysis. How Rhea-AI works. Not financial advice.